NewEdge Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.15M Sell
73,646
-236
-0.3% -$16.5K 0.03% 562
2025
Q1
$5.43M Buy
73,882
+1,414
+2% +$104K 0.03% 482
2024
Q4
$4.75M Buy
72,468
+17,721
+32% +$1.16M 0.03% 515
2024
Q3
$4.27M Buy
54,747
+5,158
+10% +$402K 0.03% 535
2024
Q2
$3.87M Buy
49,589
+5,779
+13% +$451K 0.03% 528
2024
Q1
$2.97M Buy
43,810
+5,959
+16% +$404K 0.03% 550
2023
Q4
$2.54M Buy
37,851
+3,425
+10% +$230K 0.02% 582
2023
Q3
$2.33M Buy
34,426
+3,002
+10% +$203K 0.03% 554
2023
Q2
$2.25M Sell
31,424
-1,170
-4% -$83.7K 0.03% 550
2023
Q1
$2.26M Sell
32,594
-943
-3% -$65.5K 0.03% 497
2022
Q4
$491K Buy
33,537
+1,857
+6% +$27.2K 0.01% 783
2022
Q3
$1.74M Buy
31,680
+16
+0.1% +$878 0.03% 466
2022
Q2
$2.09M Sell
31,664
-16,442
-34% -$1.09M 0.03% 425
2022
Q1
$3.19M Buy
48,106
+2,626
+6% +$174K 0.05% 319
2021
Q4
$2.65M Buy
45,480
+1,130
+3% +$65.8K 0.04% 372
2021
Q3
$2.66M Sell
44,350
-11,594
-21% -$696K 0.07% 266
2021
Q2
$3.35M Sell
55,944
-3,033
-5% -$182K 0.09% 221
2021
Q1
$2.93M Sell
58,977
-264,096
-82% -$13.1M 0.09% 220
2020
Q4
$16.2M Buy
323,073
+308,954
+2,188% +$15.4M 0.53% 46
2020
Q3
$774K Buy
+14,119
New +$774K 0.03% 451
2020
Q1
Sell
-4,913
Closed -$245K 799
2019
Q4
$245K Sell
4,913
-365
-7% -$18.2K 0.01% 719
2019
Q3
$233K Buy
+5,278
New +$233K 0.01% 705
2017
Q3
Sell
-727
Closed -$24.4K 421
2017
Q2
$24.4K Buy
+727
New +$24.4K ﹤0.01% 677